Decker Retirement Planning’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7
Closed -$553 287
2025
Q4
$553 Sell
7
-36,935
-100% -$3.2M ﹤0.01% 222
2025
Q3
$3.38M Buy
36,942
+36,894
+76,863% +$3.01M 1.86% 15
2025
Q2
$3.13K Sell
48
-26,905
-100% -$1.75M ﹤0.01% 239
2025
Q1
$1.8M Buy
+26,953
New +$1.61M 1.12% 14

Other funds holding ANIP

Decker Retirement Planning's ANIP Position: Q1 2026 in Review

Decker Retirement Planning sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 7 shares — an estimated $553 sold.

Decker Retirement Planning first reported a position in ANIP in Q1 2025 and held it in 4 quarters. The position peaked at $3.38M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Decker Retirement Planning reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Decker Retirement Planning sold 7 ANI Pharmaceuticals shares in Q1 2026, an estimated $553.
  • Decker Retirement Planning first reported a position in ANI Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Decker Retirement Planning's ANI Pharmaceuticals position peaked at $3.38M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Decker Retirement Planning's 13F filing for Q1 2026, filed 21 Apr 2026.